Depigmenting and bleaching agents: Coping with hyperpigmentation

Clinics in Dermatology

Volumn 19, Issue 4, 2001, Pages 483-488

  Katsambas, Andreas D ^a,b   Stratigos, Alexander J ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b ANDREAS SYGROS HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; ASCORBIC ACID; AZELAIC ACID; BETAMETHASONE VALERATE; BLEACHING AGENT; CATECHOL DERIVATIVE; DEPIGMENTING AGENT; DEXAMETHASONE; GLYCOLIC ACID; HYDROCORTISONE; HYDROCORTISONE ACETATE; HYDROQUINONE; KOJIC ACID; MEQUINOL; MONOBENZONE; PHENOL DERIVATIVE; RETINOIC ACID; TRIAMCINOLONE; TRIAMCINOLONE ACETONIDE; TRICHLOROACETIC ACID;

ARTICLE; DEPIGMENTATION; HUMAN; HYPERPIGMENTATION; PRIORITY JOURNAL; SKIN PIGMENTATION;

ADAPTATION, PSYCHOLOGICAL; DERMATOLOGIC AGENTS; DRUG TOLERANCE; FEMALE; HUMANS; HYPERPIGMENTATION; MALE; PATIENT SATISFACTION; PEROXIDES; TREATMENT OUTCOME;

EID: 0034848583     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-081X(01)00182-1     Document Type: Article

References (42)

1. Hydroquinone bleaching
2. Mechanism of inhibition of melaninogenesis by hydroquinone
3. Leukoderma from bleaching creams containing 2% hydroquinone
4. Mechanism of depigmentation by hydroquinone
5. Usefulness of retinoic acid in the treatment of melasma
6. Double blind comparison of azelaic acid and hydroquinone in the treatment of melasma
7. Efficacy of hydroquinone cream (USP 4%) used alone or in combination with salicylic acid peels in improving photodamage on the neck and upper chest
8. Melasma. Etiologic and therapeutic considerations
9. A hydroquinone solution in the treatment of melasma
10. Cosmetics and dermatology; Bleaching creams
11. Exogenous ochronosis
12. Exogenous ochronosis and pigmented millium from hydroquinone bleaching creams
13. Evaluation of the toxicity of the monoethyl ether of hydroquinone for mammalian melanocytes and melanoma cells
14. Monobenzylether of hydroquinone
15. Depigmentation therapy in vitiligo universalis with topical methoxyphenol and the Q-switched ruby laser
16. The treatment of hypermelanosis with 4-isopropylcatechol
17. The combination of 2% 4-hydroxyanisole (Mequinol) and 0.01% tretinoin is effective in improving the appearance of solar lentigines and related hyperpigmented lesions in two phase double-blind multicenter clinical studies
18. Azelaic acid
19. Azelaic acid as a competitive inhibitor of thioredoxin reductase in human melanoma cells
20. Ultrastructural observations on the effect of azelaic acid on normal human melanocytes and human melanoma cells
21. Azelaic acid
22. Effect of dicarboxylic acids on lentigo maligna
23. Azelaic acid therapy in disorders of hyperpigmentation
24. The treatment of melasma 20% azelaic acid versus 4% hydroquinone cream
25. Combined use of 20% azelaic acid cream and 0.05% tretinoin in topical treatment of melasma
26. Azelaic acid and glycolic acid combination therapy for facial hyperpigmentation in darker-skinned individuals; A clinical comparison with hydroquinone
27. A new formula for depigmenting human skin
28. Retinoic acid and pigment cells; a review of in-vitro and in-vivo studies
29. Topical tretinoin (retinoic acid) improves melasma; A vehicle-controlled, clinical trial
30. Topical retinoic acid (tretinoin) for melasma in black patients
31. The effect of topical tretinoin on the photodamaged skin of the Japanese
32. Inactivation of tyrosinase by dopa
33. Inhibitory effect of magnesium L-ascorbyl-2-phosphate (VC-PMG) on melanogenesis in vitro and in vivo
34. Kojic acid scavenges free radicals while potentiating leukocyte functions including free radical generation
35. Effect of kojic acid on the oxidation of DL-DOPA, norepinephrine, and dopamine by mushroom tyrosinase
36. Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid
37. Contact allergy to kojic acid in skin care products
38. Bleaching agents
39. Melasma. Classification and treatment